Last Updated on July 28, 2021 by HepFree NYC
Related Articles
-
Hepatitis A, B and C in New York City: 2022 Annual Report
The Hepatitis A, B and C in NYC: 2022 Annual Report provides the latest surveillance and programmatic data on viral hepatitis in NYC.
-
Hep C In my Own Words Essay Contest
Please help spread the word! You can easily add a link to your webpage to help get the word out about this year's essay contest. Click here to find out more. Please consider forwarding this email to your contacts and listservs.
-
Press Conference | 2016 Hep Free NYC Awareness Event
Join us to commemorate National Hepatitis Testing Day and Hispanic Hepatitis Awareness Day.
-
CME | Hep C Group Treatment in Primary Care Webinar
This one hour hepatitis C (HCV) educational webinar provides clinical and non-clinical providers an in-depth look into improving the HCV care continuum for hepatitis C through a group treatment approach.
-
Hurricane Relief Grants for Volunteer Groups
Does your neighborhood of school group need immediate emergency funding? Citizens Committee is awarding grants to volunteer-led groups providing relief to areas hit especially hard by Hurricane Sandy.
-
Press Release | 2015 World Hepatitis Day (Hep Free NYC)
See in PDF: World Hep Day 2015 Press Release Contact: Sue Preziotti 917-647-1590 sue.preziotti@yahoo.com Free Screenings, Vaccinations, Health Fairs to Mark 6th Annual World Hepatitis Day in NYC (July 28) Nearly 250,000 in NYC Infected with Hepatitis B or C Viruses, whi...
-
NYS 2020 Viral Hepatitis Strategic Plan (NYS DOH)
The NYS Viral Hepatitis Strategic Plan outlines a coordinated, comprehensive, and systematic approach that will decrease the incidence and reduce the morbidity and mortality of viral hepatitis.
-
FDA Approves Epclusa – 1st Pan-Genotypic Hep C Med
The FDA has approved the drug Epclusa to treat adult patients with chronic Hep C both with and without cirrhosis.
